[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2019

December 2019 | 34 pages | ID: P8B26345ACF7EN
GlobalData

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2019' provides an overview of Peripheral Nerve Stimulators (PNS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Nerve Stimulators (PNS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Peripheral Nerve Stimulators (PNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Nerve Stimulators (PNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Nerve Stimulators (PNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Peripheral Nerve Stimulators (PNS) Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
3.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory
3.3 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path
3.4 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date
3.5 Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials

4 PERIPHERAL NERVE STIMULATORS (PNS) - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development
4.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development

5 PERIPHERAL NERVE STIMULATORS (PNS) COMPANIES AND PRODUCT OVERVIEW

5.1 Actuated Medical Inc Company Overview
  5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Cardionomic Inc (Inactive) Company Overview
  5.2.1 Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.3 Checkpoint Surgical Inc Company Overview
  5.3.1 Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 EMKinetics, Inc. Company Overview
  5.4.1 EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Epineuron Technologies Inc Company Overview
  5.5.1 Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Gondola Medical Technologies SA Company Overview
  5.6.1 Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview
5.7 Remedee Labs SAS Company Overview
  5.7.1 Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview
5.8 Washington University School of Medicine Company Overview
  5.8.1 Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview

6 PERIPHERAL NERVE STIMULATORS (PNS)- RECENT DEVELOPMENTS

6.1 Nov 13, 2019: Remedee Labs Breakthrough Endorphin Stimulation Solution Is Unveiled
6.2 Nov 13, 2019: New clinical trial into pain management started by leading French research hospital
6.3 Sep 23, 2019: Cala Health announces positive topline data from landmark PROSPECT study for essential tremor (ET)
6.4 Aug 21, 2019: SPR Therapeutics SPRINT Peripheral Nerve Stimulation System significantly reduces opioid use in patients with low back pain, interim data show
6.5 Apr 08, 2019: Study of SPR Therapeutics Peripheral Nerve Stimulation System demonstrates significant and sustained relief of post-amputation pain
6.6 Jan 17, 2019: Cala Health enrolls first patients in landmark PROSPECT study for essential tremor
6.7 Jan 15, 2019: SPR Therapeutics names Dr. Peter Staats as Chief Medical Advisor

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
Table 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory
Table 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path
Table 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date
Table 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials
Table 6: Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development
Table 7: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
Table 8: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Peripheral Nerve Targeting System - Product Status
Table 10: Peripheral Nerve Targeting System - Product Description
Table 11: Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Neurostimulator - Cardiac Contractility - Product Status
Table 13: Neurostimulator - Cardiac Contractility - Product Description
Table 14: Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Checkpoint BEST System - Product Status
Table 16: Checkpoint BEST System - Product Description
Table 17: EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: TranStim Transdermal Neuromodulation System - Product Status
Table 19: TranStim Transdermal Neuromodulation System - Product Description
Table 20: EMKinetics, Inc. - Ongoing Clinical Trials Overview
Table 21: TranStim Transdermal Neuromodulation System - Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home
Table 22: Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Wearable Device - Peripheral Nerve Stimulation - Product Status
Table 24: Wearable Device - Peripheral Nerve Stimulation - Product Description
Table 25: Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Gondola Device - Product Status
Table 27: Gondola Device - Product Description
Table 28: Gondola Medical Technologies SA - Ongoing Clinical Trials Overview
Table 29: Gondola Device - Multi-center, Double-blind, Cross-over Randomized Study on the Use of the Medical Device Gondola for Motor Rehabilitation in Patients with Parkinson's Disease
Table 30: Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Endorphin-Stimulation Device - Product Status
Table 32: Endorphin-Stimulation Device - Product Description
Table 33: Remedee Labs SAS - Ongoing Clinical Trials Overview
Table 34: Endorphin-Stimulation Device - Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer: First in Human Evaluation in Perioperative with Regard to a Control Group
Table 35: Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Biodegradable Device - Electrical Stimulation - Product Status
Table 37: Biodegradable Device - Electrical Stimulation - Product Description
Table 38: Glossary

LIST OF FIGURES

Figure 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
Figure 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory
Figure 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path
Figure 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date
Figure 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials

COMPANIES MENTIONED

Actuated Medical Inc
Checkpoint Surgical Inc
EMKinetics, Inc.
Epineuron Technologies Inc
Gondola Medical Technologies SA
Remedee Labs SAS
Washington University School of Medicine


More Publications